Sang Beom Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sang Beom Kim has a total of 88 co-authors. Here are the top co-authors by number of shared publications:
- Ki Wha Chung
Department of Biological Sciences, Kongju National University, Gongju, Korea
11 shared publications - Byung-Ok Choi
Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
10 shared publications - Hye Mi Kwon
Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
5 shared publications - Ah Jin Lee
Department of Biological Sciences, Kongju National University, Gongju 32588, Republic of Korea
4 shared publications - Da Eun Nam
Department of Biological Sciences, Kongju National University, Gongju 32588, Korea
4 shared publications - Hye Jin Kim
Department of Health Sciences and Technology SAIHST Sungkyunkwan University Seoul Korea
4 shared publications
Latest Publications
- Open Access
- 31 August 2025
- Published by Korean Association of EMG Electrodiagnostic Medicine in Journal of Electrodiagnosis and Neuromuscular Diseases
- Vol. 27 (2) , 33-45
Clinical and Electrophysiological Features of Charcot-Marie-Tooth Patients with EGR2 Mutations
Objective: Early growth response protein 2 (EGR2) is a crucial transcription factor involved in peripheral nerve myelination. Mutations in EGR2 have been reported to cause severe forms of demyelinating neuropathy, including Charcot-Marie-Tooth disease type 1D (CMT1D), although the clinical phenotype may vary depending on the specific mutation site. In this study, we aimed to characterize the clinical, electrophysiological, and neuroimaging phenotypes of Korean Charcot-Marie-Tooth disease (CMT) patients and to identify EGR2 mutations through genetic analysis.Methods: Whole exome sequencing was conducted on CMT patients to identify pathogenic genetic variants. Clinical evaluations included neurological examinations, motor and sensory nerve conduction studies, and magnetic resonance imaging (MRI) analysis of the lower limbs in patients harboring EGR2 mutations. In silico analyses were performed to assess the potential functional impacts of the identified mutations on the EGR2 protein structure.Results: Four EGR2 mutations were identified, including the novel p.D355E variant. Patients carrying the p.R359W, p.R381H, and p.R381L mutations exhibited early onset and rapid progression of symptoms, whereas the patient with the p.D355E mutation presented with symptom onset in the late 30s and demonstrated milder clinical manifestations into their 40s. MRI findings in the p.D355E patient suggested preservation of deep posterior compartment muscles, contrasting with observations in other mutation cases. In silico predictions indicated that the p.D355E mutation is likely to result in less pronounced structural changes in EGR2, potentially explaining the observed phenotypic differences.Conclusion: This study demonstrates that clinical variability among EGR2 mutations is correlated with the characteristics and positions of amino acid substitutions. Our findings contribute to the expanding database of EGR2 mutations, enhancing the understanding of diagnosis and prognosis in demyelinating neuropathies.
- 31 August 2025
- Published by Korean Association of EMG Electrodiagnostic Medicine in Journal of Electrodiagnosis and Neuromuscular Diseases
- Vol. 27 (2) , 33-45
Open AccessClinical and Electrophysiological Features of Charcot-Marie-Tooth Patients with EGR2 Mutations
Objective: Early growth response protein 2 (EGR2) is a crucial transcription factor involved in peripheral nerve myelination. Mutations in EGR2 have been reported to cause severe forms of demyelinating neuropathy, including Charcot-Marie-Tooth disease type 1D (CMT1D), although the clinical phenotype may vary depending on the specific mutation site. In this study, we aimed to characterize the clinical, electrophysiological, and neuroimaging phenotypes of Korean Charcot-Marie-Tooth disease (CMT) patients and to identify EGR2 mutations through genetic analysis.Methods: Whole exome sequencing was conducted on CMT patients to identify pathogenic genetic variants. Clinical evaluations included neurological examinations, motor and sensory nerve conduction studies, and magnetic resonance imaging (MRI) analysis of the lower limbs in patients harboring EGR2 mutations. In silico analyses were performed to assess the potential functional impacts of the identified mutations on the EGR2 protein structure.Results: Four EGR2 mutations were identified, including the novel p.D355E variant. Patients carrying the p.R359W, p.R381H, and p.R381L mutations exhibited early onset and rapid progression of symptoms, whereas the patient with the p.D355E mutation presented with symptom onset in the late 30s and demonstrated milder clinical manifestations into their 40s. MRI findings in the p.D355E patient suggested preservation of deep posterior compartment muscles, contrasting with observations in other mutation cases. In silico predictions indicated that the p.D355E mutation is likely to result in less pronounced structural changes in EGR2, potentially explaining the observed phenotypic differences.Conclusion: This study demonstrates that clinical variability among EGR2 mutations is correlated with the characteristics and positions of amino acid substitutions. Our findings contribute to the expanding database of EGR2 mutations, enhancing the understanding of diagnosis and prognosis in demyelinating neuropathies.
- Open Access
- 9 June 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (12) , 6378
Compound Heterozygous Mutations of SACS in a Korean Cohort Study of Charcot-Marie-Tooth Disease Concurrent Cerebellar Ataxia and Spasticity
Mutations in the SACS gene are associated with autosomal recessive spastic ataxia of Charlevoix-Saguenay disease (ARSACS) or complex clinical phenotypes of Charcot-Marie-Tooth disease (CMT). This study aimed to identify SACS mutations in a Korean CMT cohort with cerebellar ataxia and spasticity by whole exome sequencing (WES). As a result, eight pathogenic SACS mutations in four families were identified as the underlying causes of these complex phenotypes. The prevalence of CMT families with SACS mutations was determined to be 0.3%. All the patients showed sensory, motor, and gait disturbances with increased deep tendon reflexes. Lower limb magnetic resonance imaging (MRI) was performed in four patients and all had fatty replacements. Of note, they all had similar fatty infiltrations between the proximal and distal lower limb muscles, different from the neuromuscular imaging feature in most CMT patients without SACS mutations who had distal dominant fatty involvement. Therefore, these findings were considered a characteristic feature in CMT patients with SACS mutations. Although further studies with more cases are needed, our results highlight lower extremity MRI findings in CMT patients with SACS mutations and broaden the clinical spectrum. We suggest screening for SACS in recessive CMT patients with complex phenotypes of ataxia and spasticity.
- 9 June 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (12) , 6378
Open AccessCompound Heterozygous Mutations of SACS in a Korean Cohort Study of Charcot-Marie-Tooth Disease Concurrent Cerebellar Ataxia and Spasticity
Mutations in the SACS gene are associated with autosomal recessive spastic ataxia of Charlevoix-Saguenay disease (ARSACS) or complex clinical phenotypes of Charcot-Marie-Tooth disease (CMT). This study aimed to identify SACS mutations in a Korean CMT cohort with cerebellar ataxia and spasticity by whole exome sequencing (WES). As a result, eight pathogenic SACS mutations in four families were identified as the underlying causes of these complex phenotypes. The prevalence of CMT families with SACS mutations was determined to be 0.3%. All the patients showed sensory, motor, and gait disturbances with increased deep tendon reflexes. Lower limb magnetic resonance imaging (MRI) was performed in four patients and all had fatty replacements. Of note, they all had similar fatty infiltrations between the proximal and distal lower limb muscles, different from the neuromuscular imaging feature in most CMT patients without SACS mutations who had distal dominant fatty involvement. Therefore, these findings were considered a characteristic feature in CMT patients with SACS mutations. Although further studies with more cases are needed, our results highlight lower extremity MRI findings in CMT patients with SACS mutations and broaden the clinical spectrum. We suggest screening for SACS in recessive CMT patients with complex phenotypes of ataxia and spasticity.
- Open Access
- 20 May 2024
- Published by MDPI AG in Preprints.org
Compound Heterozygous Mutations of SACS in a Korean Cohort Study of Charcot-Marie-Tooth Disease Concurrent Cerebellar Ataxia and Spasticity
Mutations in the SACS gene are associated with autosomal recessive spastic ataxia of Charlevoix-Saguenay disease (ARSACS) or complex clinical phenotypes of Charcot-Marie-Tooth disease (CMT). This study aimed to identify SACS mutations in a Korean CMT cohort with cerebellar ataxia and spasticity. As a result, eight pathogenic SACS mutations in four families were identified as the underlying causes of these complex phenotypes. The prevalence of CMT families with SACS mutations was determined to be 0.3%. All the patients showed sensory, motor, and gait disturbances with increased deep tendon reflexes. Lower limb magnetic resonance imaging (MRI) was done in four patients, and all had fatty replacements. Of note, they all had similar fatty infiltrations between the proximal and distal lower limb muscles, different from the neuromuscular imaging feature in most CMT patients without SACS mutations who had distal dominant fatty involvement. Therefore, these findings were considered a characteristic feature in CMT patients with SACS mutations. Although further studies with more cases are needed, our results highlight lower extremity MRI findings in CMT patients with SACS mutations and broaden the clinical spectrum. We suggest screening for SACS in recessive CMT patients with complex phenotypes of ataxia and spasticity.
- 20 May 2024
- Published by MDPI AG in Preprints.org
Open AccessCompound Heterozygous Mutations of SACS in a Korean Cohort Study of Charcot-Marie-Tooth Disease Concurrent Cerebellar Ataxia and Spasticity
Mutations in the SACS gene are associated with autosomal recessive spastic ataxia of Charlevoix-Saguenay disease (ARSACS) or complex clinical phenotypes of Charcot-Marie-Tooth disease (CMT). This study aimed to identify SACS mutations in a Korean CMT cohort with cerebellar ataxia and spasticity. As a result, eight pathogenic SACS mutations in four families were identified as the underlying causes of these complex phenotypes. The prevalence of CMT families with SACS mutations was determined to be 0.3%. All the patients showed sensory, motor, and gait disturbances with increased deep tendon reflexes. Lower limb magnetic resonance imaging (MRI) was done in four patients, and all had fatty replacements. Of note, they all had similar fatty infiltrations between the proximal and distal lower limb muscles, different from the neuromuscular imaging feature in most CMT patients without SACS mutations who had distal dominant fatty involvement. Therefore, these findings were considered a characteristic feature in CMT patients with SACS mutations. Although further studies with more cases are needed, our results highlight lower extremity MRI findings in CMT patients with SACS mutations and broaden the clinical spectrum. We suggest screening for SACS in recessive CMT patients with complex phenotypes of ataxia and spasticity.
- Open Access
- 31 December 2023
- Published by Korean Society of Neuroimmunology in Journal of Multiple Sclerosis and Neuroimmunology
- Vol. 14 (2) , 80-86
Transocular Ultrasonography in Central Nervous System (CNS) Demyelinating Disease: A Narrative Review of the Clinical Utility in Optic Neuritis and CNS Demyelinating Disease
■ 서론 시신경염은 비교적 흔하게 발생하는 중추신경계(central nervous system) 염증질환으로 급성 또는 아급성의 시력 및 시 야장애나 색각이상을 주 증상으로 한다. 이는 주로 특발시신경 염(idiopathic optic neuritis) 단독으로 나타나기도 하지만, 다 발경화증(multiple sclerosis), 시신경척수염범주질환(neuromyelitis optica spectrum disorder),
- 31 December 2023
- Published by Korean Society of Neuroimmunology in Journal of Multiple Sclerosis and Neuroimmunology
- Vol. 14 (2) , 80-86
Open AccessTransocular Ultrasonography in Central Nervous System (CNS) Demyelinating Disease: A Narrative Review of the Clinical Utility in Optic Neuritis and CNS Demyelinating Disease
■ 서론 시신경염은 비교적 흔하게 발생하는 중추신경계(central nervous system) 염증질환으로 급성 또는 아급성의 시력 및 시 야장애나 색각이상을 주 증상으로 한다. 이는 주로 특발시신경 염(idiopathic optic neuritis) 단독으로 나타나기도 하지만, 다 발경화증(multiple sclerosis), 시신경척수염범주질환(neuromyelitis optica spectrum disorder),
- 20 January 2023
- Published by Wiley in Journal of the Peripheral Nervous System
- Vol. 28 (1) , 108-118
INF2 mutations in patients with a broad phenotypic spectrum of Charcot‐Marie‐Tooth disease and focal segmental glomerulosclerosis
Mutations in INF2 are associated with the complex symptoms of Charcot‐Marie‐Tooth disease (CMT) and focal segmental glomerulosclerosis (FSGS). To date, more than 100 and 30 genes have been reported to cause these disorders, respectively. This study aimed to identify INF2 mutations in Korean patients with CMT. This study was conducted with 743 Korean families with CMT who were negative for PMP22 duplication. In addition, a family with FSGS was included in this study. INF2 mutations were screened using whole exome sequencing (WES) and filtering processes. As the results, four pathogenic INF2 mutations were identified in families with different clinical phenotypes: p.L78P and p.L132P in families with symptoms of both CMT and FSGS; p.C104Y in a family with CMT; and p.R218Q in a family with FSGS. Moreover, different CMT types were observed in families with CMT symptoms: CMT1 in two families and Int‐CMT in another family. Hearing loss was observed in two families with CMT1. Pathogenicity was predicted by in silico analyses, and considerable conformational changes were predicted in the mutant proteins. Two mutations (p.L78P and p.C104Y) were unreported, and three families showed de novo mutations that were putatively occurred from fathers. This study suggests that patients with INF2 mutations show a broad phenotypic spectrum: CMT1, CMT1 + FSGS, CMTDIE + FSGS, and FSGS. Therefore, the genotype‐phenotype correlation may be more complex than previously recognized. We believe that this study expands the clinical spectrum of patients with INF2 mutations and will be helpful in the molecular diagnosis of CMT and FSGS.
- 20 January 2023
- Published by Wiley in Journal of the Peripheral Nervous System
- Vol. 28 (1) , 108-118
INF2 mutations in patients with a broad phenotypic spectrum of Charcot‐Marie‐Tooth disease and focal segmental glomerulosclerosis
Mutations in INF2 are associated with the complex symptoms of Charcot‐Marie‐Tooth disease (CMT) and focal segmental glomerulosclerosis (FSGS). To date, more than 100 and 30 genes have been reported to cause these disorders, respectively. This study aimed to identify INF2 mutations in Korean patients with CMT. This study was conducted with 743 Korean families with CMT who were negative for PMP22 duplication. In addition, a family with FSGS was included in this study. INF2 mutations were screened using whole exome sequencing (WES) and filtering processes. As the results, four pathogenic INF2 mutations were identified in families with different clinical phenotypes: p.L78P and p.L132P in families with symptoms of both CMT and FSGS; p.C104Y in a family with CMT; and p.R218Q in a family with FSGS. Moreover, different CMT types were observed in families with CMT symptoms: CMT1 in two families and Int‐CMT in another family. Hearing loss was observed in two families with CMT1. Pathogenicity was predicted by in silico analyses, and considerable conformational changes were predicted in the mutant proteins. Two mutations (p.L78P and p.C104Y) were unreported, and three families showed de novo mutations that were putatively occurred from fathers. This study suggests that patients with INF2 mutations show a broad phenotypic spectrum: CMT1, CMT1 + FSGS, CMTDIE + FSGS, and FSGS. Therefore, the genotype‐phenotype correlation may be more complex than previously recognized. We believe that this study expands the clinical spectrum of patients with INF2 mutations and will be helpful in the molecular diagnosis of CMT and FSGS.
- Open Access
- 31 December 2022
- Published by Korean Association of EMG Electrodiagnostic Medicine in Journal of Electrodiagnosis and Neuromuscular Diseases
- Vol. 24 (3) , 62-69
MPZ-, GDAP1-, and NEFL-Related Charcot-Marie-Tooth Disease with Diverse Clinical and Electrophysiological Phenotypes
Charcot-Marie-Tooth disease (CMT) is a spectrum of clinically and genetically heterogeneous peripheral neuropathies. CMT can be classified into demyelinating, intermediate, or axonal neuropathy based on clinical, histopathological, and electrophysiological findings. Approximately 140 genes have been reported to be associated with CMT. Mutations in the myelin protein zero (MPZ), ganglioside-induced differentiation related protein 1 (GDAP1), and neurofilament light-chain polypeptide gene (NEFL) genes have been reported to cause all three types of CMT, which is noteworthy because most CMT-related genes cause a single type of neuropathy (either demyelinating or axonal). In contrast, it remains unclear why these genes cause several types of CMT. CMT is presently incurable; however, ongoing attempts to treat CMT with various drugs and dietary supplements have increased the importance of an exact genetic diagnosis for precision medicine. Therefore, it is important to identify the causative mutations and compare the associated clinical characteristics. Taken together, a comparison of causative mutations and clinical features of patients with MPZ, GDAP1, and NEFL mutations will be the first step in understanding how different types of CMT are caused, and will enable a molecular genetic diagnosis. In this review, we describe the clinical, electrophysiological, and genetic characteristics of MPZ-, GDAP1-, and NEFL-related CMT.
- 31 December 2022
- Published by Korean Association of EMG Electrodiagnostic Medicine in Journal of Electrodiagnosis and Neuromuscular Diseases
- Vol. 24 (3) , 62-69
Open AccessMPZ-, GDAP1-, and NEFL-Related Charcot-Marie-Tooth Disease with Diverse Clinical and Electrophysiological Phenotypes
Charcot-Marie-Tooth disease (CMT) is a spectrum of clinically and genetically heterogeneous peripheral neuropathies. CMT can be classified into demyelinating, intermediate, or axonal neuropathy based on clinical, histopathological, and electrophysiological findings. Approximately 140 genes have been reported to be associated with CMT. Mutations in the myelin protein zero (MPZ), ganglioside-induced differentiation related protein 1 (GDAP1), and neurofilament light-chain polypeptide gene (NEFL) genes have been reported to cause all three types of CMT, which is noteworthy because most CMT-related genes cause a single type of neuropathy (either demyelinating or axonal). In contrast, it remains unclear why these genes cause several types of CMT. CMT is presently incurable; however, ongoing attempts to treat CMT with various drugs and dietary supplements have increased the importance of an exact genetic diagnosis for precision medicine. Therefore, it is important to identify the causative mutations and compare the associated clinical characteristics. Taken together, a comparison of causative mutations and clinical features of patients with MPZ, GDAP1, and NEFL mutations will be the first step in understanding how different types of CMT are caused, and will enable a molecular genetic diagnosis. In this review, we describe the clinical, electrophysiological, and genetic characteristics of MPZ-, GDAP1-, and NEFL-related CMT.
- Open Access
Peripheral Myelin Protein 22 Gene Mutations in Charcot-Marie-Tooth Disease Type 1E Patients
Duplication and deletion of the peripheral myelin protein 22 (PMP22) gene cause Charcot-Marie-Tooth disease type 1A (CMT1A) and hereditary neuropathy with liability to pressure palsies (HNPP), respectively, while point mutations or small insertions and deletions (indels) usually cause CMT type 1E (CMT1E) or HNPP. This study was performed to identify PMP22 mutations and to analyze the genotype–phenotype correlation in Korean CMT families. By the application of whole-exome sequencing (WES) and targeted gene panel sequencing (TS), we identified 14 pathogenic or likely pathogenic PMP22 mutations in 21 families out of 850 CMT families who were negative for 17p12 (PMP22) duplication. Most mutations were located in the well-conserved transmembrane domains. Of these, eight mutations were not reported in other populations. High frequencies of de novo mutations were observed, and the mutation sites of c.68C>G and c.215C>T were suggested as the mutational hotspots. Affected individuals showed an early onset-severe phenotype and late onset-mild phenotype, and more than 40% of the CMT1E patients showed hearing loss. Physical and electrophysiological symptoms of the CMT1E patients were more severely damaged than those of CMT1A while similar to CMT1B caused by MPZ mutations. Our results will be useful for the reference data of Korean CMT1E and the molecular diagnosis of CMT1 with or without hearing loss.
Open AccessPeripheral Myelin Protein 22 Gene Mutations in Charcot-Marie-Tooth Disease Type 1E Patients
Duplication and deletion of the peripheral myelin protein 22 (PMP22) gene cause Charcot-Marie-Tooth disease type 1A (CMT1A) and hereditary neuropathy with liability to pressure palsies (HNPP), respectively, while point mutations or small insertions and deletions (indels) usually cause CMT type 1E (CMT1E) or HNPP. This study was performed to identify PMP22 mutations and to analyze the genotype–phenotype correlation in Korean CMT families. By the application of whole-exome sequencing (WES) and targeted gene panel sequencing (TS), we identified 14 pathogenic or likely pathogenic PMP22 mutations in 21 families out of 850 CMT families who were negative for 17p12 (PMP22) duplication. Most mutations were located in the well-conserved transmembrane domains. Of these, eight mutations were not reported in other populations. High frequencies of de novo mutations were observed, and the mutation sites of c.68C>G and c.215C>T were suggested as the mutational hotspots. Affected individuals showed an early onset-severe phenotype and late onset-mild phenotype, and more than 40% of the CMT1E patients showed hearing loss. Physical and electrophysiological symptoms of the CMT1E patients were more severely damaged than those of CMT1A while similar to CMT1B caused by MPZ mutations. Our results will be useful for the reference data of Korean CMT1E and the molecular diagnosis of CMT1 with or without hearing loss.
- 24 May 2022
- Published by Springer Nature in Genes & Genomics
- Vol. 44 (8) , 1007-1016
Identification and clinical characterization of Charcot-Marie-Tooth disease type 1C patients with LITAF p.G112S mutation
Background Charcot-Marie-Tooth disease type 1C (CMT1C) is a rare subtype associated with LITAF gene mutations. Until now, only a few studies have reported the clinical features of CMT1C. Objective This study was performed to find CMT1C patients with mutation of LITAF in a Korean CMT cohort and to characterize their clinical features. Methods In total, 1,143 unrelated Korean families with CMT were enrolled in a cohort. We performed whole exome sequencing to identify LITAF mutations, and examined clinical phenotypes including electrophysiological and MRI features for the identified CMT1C patients. Results We identified 10 CMT1C patients from three unrelated families with p.G112S mutation in LITAF. The frequency of CMT1C among CMT1 patients was 0.59%, which is similar to reports from Western populations. CMT1C patients showed milder symptoms than CMT1A patients. The mean CMT neuropathy score version 2 was 7.7, and the mean functional disability scale was 1.0. Electrophysiological findings showed a conduction block in 22% of affected individuals. Lower extremity MRIs showed that the superficial posterior and anterolateral compartments of the calf were predominantly affected. Conclusions We found a conduction block in Korean CMT1C patients with p.G112S mutation and first described the characteristic MRI findings of the lower extremities in patients with LITAF mutation. These findings will be helpful for genotype–phenotype correlation and will widen understanding about the clinical spectrum of CMT1C.
- 24 May 2022
- Published by Springer Nature in Genes & Genomics
- Vol. 44 (8) , 1007-1016
Identification and clinical characterization of Charcot-Marie-Tooth disease type 1C patients with LITAF p.G112S mutation
Background Charcot-Marie-Tooth disease type 1C (CMT1C) is a rare subtype associated with LITAF gene mutations. Until now, only a few studies have reported the clinical features of CMT1C. Objective This study was performed to find CMT1C patients with mutation of LITAF in a Korean CMT cohort and to characterize their clinical features. Methods In total, 1,143 unrelated Korean families with CMT were enrolled in a cohort. We performed whole exome sequencing to identify LITAF mutations, and examined clinical phenotypes including electrophysiological and MRI features for the identified CMT1C patients. Results We identified 10 CMT1C patients from three unrelated families with p.G112S mutation in LITAF. The frequency of CMT1C among CMT1 patients was 0.59%, which is similar to reports from Western populations. CMT1C patients showed milder symptoms than CMT1A patients. The mean CMT neuropathy score version 2 was 7.7, and the mean functional disability scale was 1.0. Electrophysiological findings showed a conduction block in 22% of affected individuals. Lower extremity MRIs showed that the superficial posterior and anterolateral compartments of the calf were predominantly affected. Conclusions We found a conduction block in Korean CMT1C patients with p.G112S mutation and first described the characteristic MRI findings of the lower extremities in patients with LITAF mutation. These findings will be helpful for genotype–phenotype correlation and will widen understanding about the clinical spectrum of CMT1C.
- Open Access
- 31 December 2021
- Published by Korean Society of Intraoperative Neurophysiological monitoring in Journal of Intraoperative Neurophysiology
- Vol. 3 (2) , 67-74
Intraoperative neurophysiological monitoring in spinal cord surgery
- 31 December 2021
- Published by Korean Society of Intraoperative Neurophysiological monitoring in Journal of Intraoperative Neurophysiology
- Vol. 3 (2) , 67-74
Open AccessIntraoperative neurophysiological monitoring in spinal cord surgery
- 23 November 2021
- Published by Wiley in Journal of the Peripheral Nervous System
- Vol. 27 (1) , 38-49
Variants of aminoacyl‐tRNA synthetase genes in Charcot‐Marie‐Tooth disease: A Korean cohort study
Background and Aims Charcot-Marie-Tooth disease (CMT) and related diseases are a genetically and clinically heterogeneous group of peripheral neuropathies. Particularly, mutations in several aminoacyl-tRNA synthetase (ARS) genes have been reported to cause axonal CMT (CMT2) or distal hereditary motor neuropathy (dHMN). However, the common pathogenesis among CMT subtypes by different ARS gene defects is not well understood. This study was performed to investigate ARS gene mutations in a CMT cohort of 710 Korean families. Methods Whole exome sequencing was applied to 710 CMT patients who were negative for PMP22 duplication. Results We identified 12 disease-causing variants (from 13 families) in GARS1, AARS1, HARS1, WARS1, and YARS1 genes. Seven variants were determined to be novel. The frequency of overall ARS gene mutations was 1.22% among all independent patients diagnosed with CMT and 1.83% in patients negative for PMP22 duplication. WARS1 mutations have been reported to cause dHMN; however, in our patients with WARS1 variants, CMT was associated with sensory involvement. Interpretation We analyzed genotype-phenotype correlations and expanded the phenotypic spectrum of patients with CMT possessing ARS gene variants. We also characterized clinical phenotypes according to ARS genes. This study will be useful for performing exact molecular and clinical diagnoses, and providing reference data for other population studies.
- 23 November 2021
- Published by Wiley in Journal of the Peripheral Nervous System
- Vol. 27 (1) , 38-49
Variants of aminoacyl‐tRNA synthetase genes in Charcot‐Marie‐Tooth disease: A Korean cohort study
Background and Aims Charcot-Marie-Tooth disease (CMT) and related diseases are a genetically and clinically heterogeneous group of peripheral neuropathies. Particularly, mutations in several aminoacyl-tRNA synthetase (ARS) genes have been reported to cause axonal CMT (CMT2) or distal hereditary motor neuropathy (dHMN). However, the common pathogenesis among CMT subtypes by different ARS gene defects is not well understood. This study was performed to investigate ARS gene mutations in a CMT cohort of 710 Korean families. Methods Whole exome sequencing was applied to 710 CMT patients who were negative for PMP22 duplication. Results We identified 12 disease-causing variants (from 13 families) in GARS1, AARS1, HARS1, WARS1, and YARS1 genes. Seven variants were determined to be novel. The frequency of overall ARS gene mutations was 1.22% among all independent patients diagnosed with CMT and 1.83% in patients negative for PMP22 duplication. WARS1 mutations have been reported to cause dHMN; however, in our patients with WARS1 variants, CMT was associated with sensory involvement. Interpretation We analyzed genotype-phenotype correlations and expanded the phenotypic spectrum of patients with CMT possessing ARS gene variants. We also characterized clinical phenotypes according to ARS genes. This study will be useful for performing exact molecular and clinical diagnoses, and providing reference data for other population studies.